These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 20098782)
21. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
22. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance]. Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338 [TBL] [Abstract][Full Text] [Related]
23. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii. Shi WF; Jiang JP; Mi ZH Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800 [TBL] [Abstract][Full Text] [Related]
24. Efflux pump overexpression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem. Luo L; Jiang X; Wu Q; Wei L; Li J; Ying C Chemotherapy; 2011; 57(1):77-84. PubMed ID: 21346352 [TBL] [Abstract][Full Text] [Related]
25. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Peleg AY; Adams J; Paterson DL Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan. Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741 [TBL] [Abstract][Full Text] [Related]
27. [Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech Republic]. Nemec A; Maixnerová M Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):223-8. PubMed ID: 15558451 [TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. Yun SH; Choi CW; Kwon SO; Park GW; Cho K; Kwon KH; Kim JY; Yoo JS; Lee JC; Choi JS; Kim S; Kim SI J Proteome Res; 2011 Feb; 10(2):459-69. PubMed ID: 21053951 [TBL] [Abstract][Full Text] [Related]
29. RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ruzin A; Immermann FW; Bradford PA Microb Drug Resist; 2010 Jun; 16(2):87-9. PubMed ID: 20438348 [TBL] [Abstract][Full Text] [Related]
30. New antibiotics, efflux pumps and overcoming resistance. McIntosh E; David G Cas Lek Cesk; 2007; 146(2):102-6; discussion 107-8. PubMed ID: 17373102 [TBL] [Abstract][Full Text] [Related]
31. [Association of genotype of OXA-carbapenemases of Acinetobacter baumannii and antibiotic resistance]. Du R; Feng P; Chen HL; Yu RJ; Gao YY; Shi YH; Sun H; Wang YJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):272-4, 278. PubMed ID: 19462905 [TBL] [Abstract][Full Text] [Related]
32. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. Rajamohan G; Srinivasan VB; Gebreyes WA J Antimicrob Chemother; 2010 Feb; 65(2):228-32. PubMed ID: 20008046 [TBL] [Abstract][Full Text] [Related]
33. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii. Cortez-Cordova J; Kumar A Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839 [TBL] [Abstract][Full Text] [Related]
34. Development of a high-throughput cloning strategy for characterization of Acinetobacter baumannii drug transporter proteins. Eijkelkamp BA; Hassan KA; Paulsen IT; Brown MH J Mol Microbiol Biotechnol; 2011; 20(4):211-9. PubMed ID: 21778766 [TBL] [Abstract][Full Text] [Related]
35. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Su XZ; Chen J; Mizushima T; Kuroda T; Tsuchiya T Antimicrob Agents Chemother; 2005 Oct; 49(10):4362-4. PubMed ID: 16189122 [TBL] [Abstract][Full Text] [Related]
36. Characterization of beta-ketoadipate pathway from multi-drug resistance bacterium, Acinetobacter baumannii DU202 by proteomic approach. Park SH; Kim JW; Yun SH; Leem SH; Kahng HY; Kim SI J Microbiol; 2006 Dec; 44(6):632-40. PubMed ID: 17205041 [TBL] [Abstract][Full Text] [Related]
37. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Marchand I; Damier-Piolle L; Courvalin P; Lambert T Antimicrob Agents Chemother; 2004 Sep; 48(9):3298-304. PubMed ID: 15328088 [TBL] [Abstract][Full Text] [Related]
38. Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii. Verma P; Tiwari M; Tiwari V Int J Biol Macromol; 2022 Sep; 217():592-605. PubMed ID: 35841965 [TBL] [Abstract][Full Text] [Related]
39. Acinetobacter baumannii: a universal threat to public health? Giamarellou H; Antoniadou A; Kanellakopoulou K Int J Antimicrob Agents; 2008 Aug; 32(2):106-19. PubMed ID: 18571905 [TBL] [Abstract][Full Text] [Related]
40. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Huys G; Cnockaert M; Vaneechoutte M; Woodford N; Nemec A; Dijkshoorn L; Swings J Res Microbiol; 2005 Apr; 156(3):348-55. PubMed ID: 15808938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]